SGLT Inhibitors Quiz

1. Common side effects of the SGLT2 inhibitors currently on the Australian market include:

A) Increased frequency of urination.

B) Increased chance of genital infections.

C) Increased risk of diabetic ketoacidosis even if glucose levels are not elevated.

D) All the above.

Correct! Wrong!

2. Mrs Jennings is a long-standing customer of your pharmacy. She was diagnosed with diabetes some years ago and has recently started a new medication called empagliflozin. She tells you all seems to be going well but she just needs something for a vaginal itch that she has had for several days. Nothing else seems to have changed for her. What scenario is the best for Mrs Jennings?

Please select 2 correct answers

A) After discussion you give Mrs Jennings a seven-day cream and a probiotic and ask her to follow up with her GP if symptoms do not resolve after this course.

B) Ask Mrs Jennings to purchase some probiotic containing yoghurt from the supermarket.

C) Explain to Mrs Jennings that it is quite possible the itch is caused by her new diabetes medication. Establish her understanding of the mechanism of empagliflozin. Invite Mrs Jennings for a Diabetes Medscheck. Provide Mrs Jennings products for symptom relief and refer to appropriate allied health professionals. Log all interventions using the Electronic Intervention Log @ Pharmacy Diabetes.

D) Send Mrs Jennings to the GP immediately.

Correct! Wrong!

3. Mr Parker has presented a prescription for Dapagliflozin. He tells you he has not started this yet, but it is one that his doctor suggested he start since he suffered a heart attack due late last year. He is unsure if he should continue his other diabetes medication. His dispense history shows he is on metformin and a DPP4 inhibitor. Of the following scenarios which describes the best for Mr Parker’s health?

Please select 2 correct answers

A) Invite Mr Parker for a Diabetes Medscheck and counsel him on the mechanism of action of dapagliflozin, side effects and why it is used for those individuals who have had a history of heart attacks. Ensure he understands what symptoms to watch for given the small chance it can cause diabetic ketoacidosis. Invite Mr Parker to monitor both his glucose and ketone levels. Ensure Mr Parker understands that this medication is in conjunction with his other diabetes medications not instead of. Refer to allied health care professionals if required, including a credentialled diabetes educator for sick day management and further education about his diabetes management.

B) Counsel Mr Parker on the mechanism of action of dapagliflozin, side effects and why it is used for those individuals who have had a history of heart attacks.

C) Dispense the medication and give Mr Parker a CMI. He can have a read of this.

D) Send Mr Parker back to the doctor. If Mr Parker needs three oral medications for his diabetes, it is time to start insulin.

Correct! Wrong!

4. SGLT2 inhibitors should be ceased prior to major surgery. Those scheduled for non-urgent surgery who have not ceased their SGLT2 inhibitor should be assessed, and consideration should be given to postponing the procedure. Treatment with the SGLT2 inhibitor maybe restarted once oral intake is normal.

A) True

B) False

Correct! Wrong!

Acarbose needs to be taken immediately before meals or with the first mouthful to be effective. If Mr Barnes is experiencing gastrointestinal side effects when taking before meals this may be due to having too much carbohydrate in his diet and he may need referral for extra education or referral to a dietitian.rnrn

SGLT2 inhibitors need insulin production to exert an effect on blood glucose levels.

A) True

B) False

Correct! Wrong!

SGLT2 inhibitors have also been shown to have a positive cardiovascular effect for those individuals who have type 2 diabetes.

A) True

B) False

Correct! Wrong!

Sodium Glucose Co-Transporter-2 are proteins that occur in the

A) Kidneys

B) Brain

C) Liver

D) Intestine

E) All the above

Correct! Wrong!

SGLT2 inhibitors have the potential to cause hypoglycaemia if started as part of the management with insulin for someone with type 2 diabetes.

A) True

B) False

Correct! Wrong!

Ketoacidosis has been reported in individuals with type 2 diabetes taking SGLT2 inhibitors. While rare, individuals should be counselled on what to expect and who to contact should they experience side effects including

A) Nausea and vomiting

B) Abdominal pain

C) Malaise

D) Shortness of breath

E) All the above

Correct! Wrong!

SGLT Inhibitors Quiz

Sorry! All your answers are incorrect. Better luck next time!!

Your one answer is correct .. others are wrong

Your 4 answers correct out of 9

Nearly Good Performance !!!

Hurray !!! All answers are correct....

1. Common side effects of the SGLT2 inhibitors currently on the Australian market include:

SGLT2 inhibitors need insulin production to exert an effect on blood glucose levels.

SGLT2 inhibitors have also been shown to have a positive cardiovascular effect for those individuals who have type 2 diabetes.

Sodium Glucose Co-Transporter-2 are proteins that occur in the

SGLT2 inhibitors have the potential to cause hypoglycaemia if started as part of the management with insulin for someone with type 2 diabetes.

Ketoacidosis has been reported in individuals with type 2 diabetes taking SGLT2 inhibitors. While rare, individuals should be counselled on what to expect and who to contact should they experience side effects including

Leave a comment

Cancel reply

1. Common side effects of the SGLT2 inhibitors currently on the Australian market include:

SGLT2 inhibitors need insulin production to exert an effect on blood glucose levels.

SGLT2 inhibitors have also been shown to have a positive cardiovascular effect for those individuals who have type 2 diabetes.

Sodium Glucose Co-Transporter-2 are proteins that occur in the

SGLT2 inhibitors have the potential to cause hypoglycaemia if started as part of the management with insulin for someone with type 2 diabetes.

Ketoacidosis has been reported in individuals with type 2 diabetes taking SGLT2 inhibitors. While rare, individuals should be counselled on what to expect and who to contact should they experience side effects including

Leave a comment

Cancel reply

Coming Soon..

Coming Soon..

Login